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Am J Physiol Regul Integr Comp Physiol 296: R1797–R1806, 2009. First
published April 1, 2009; doi:10.1152/ajpregu.90730.2008.—Commis-
sural nucleus of the solitary tract (commNTS) lesions transitorily (first 5
days) reduce mean arterial pressure (MAP) in spontaneously hyperten-
sive rats (SHR), and lesions of the tissue surrounding the anteroventral
third ventricle (AV3V region) chronically reduce MAP in other models
of hypertension. In the present study, we investigated the effects of
combined AV3VcommNTS electrolytic lesions on MAP and heart rate
(HR) in conscious SHR. Baseline MAP and HR were recorded in male
SHR before and for the next 40 days after sham or AV3V lesions
combined with sham or commNTS lesions. The AV3V lesions produced
no change in MAP in SHR, while commNTS lesions reduced MAP
acutely (121 2 to 127 3 mmHg in the 1st and 5th days, respectively,
vs. prelesion: 192  4 mmHg) but not chronically (from 10 to 40 days).
However, combined AV3VcommNTS lesions reduced MAP of SHR
chronically (119  2 to 161  4 mmHg, in the 1st and 40th day,
respectively, vs. prelesion levels: 186 4 mmHg) or sham-lesioned SHR
(187  4 to 191  6 mmHg). Sympathetic and angiotensinergic
blockade produced less reduction in MAP in SHR with
AV3VcommNTS-lesions, and there was no relationship between
changes on water and food intake, body weight, or urinary excre-
tion produced by AV3VcommNTS lesions with the changes in
MAP. The present findings suggest that in the absence of the
commNTS, the AV3V region contributes to the hypertension
observed in SHR by mechanisms that appear to involve enhanced
angiotensinergic and sympathetic activity.
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IN SPONTANEOUSLY HYPERTENSIVE rats (SHR), arterial pressure
starts rising a few weeks after birth and reaches hypertensive
levels 12 to 14 wk later, mainly due to increases in sympathetic
and angiotensinergic activities and the involvement of central
mechanisms (7, 20, 24, 29). Central mechanisms for the de-
velopment and maintenance of hypertension in SHR are
present in the brain stem, particularly in the commissural
nucleus of the solitary tract (commNTS) and area postrema
(AP) (25, 36, 37, 38). Inhibition of the commNTS neurons with
injections of -aminobutyric acid (GABA) reduces sympathetic
nerve discharges (SND) and mean arterial pressure (MAP) in
SHR (37). Moreover, electrolytic lesions of the commNTS reduce
MAP to normotensive levels in SHR in the first 5 days after
lesions with MAP returning to hypertensive prelesion levels
around 10 days after lesions (36). However, in contrast to the
effects in SHR, in normotensive rats, electrolytic lesions or
GABA injection in the commNTS produce no change in
baseline MAP, which suggests that commNTS pressor mech-
anisms are particularly active in SHR increasing SND and
MAP (37). Besides the antihypertensive effects in SHR, com-
mNTS lesions also abolish the pressor responses to peripheral
chemoreceptor activation without changing baroreflex control
of heart rate (HR) in normotensive rats and SHR (13, 36, 38).
A relationship between increases in SND and increases in
chemoreflex activation in SHR has been reported (16, 19, 33).
Therefore, a suggestion is that the antihypertensive effects of
commNTS lesions in SHR might be related to the blockade of
chemoreflex by these lesions (36, 37). However, one important
question is why is MAP only transitorily reduced by com-
mNTS lesions in SHR, while chemoreflex is permanently
impaired? Probably commNTS pressor mechanisms are re-
placed by another pressor mechanism allowing MAP to return
to hypertensive levels 10 days after commNTS lesions in SHR.
Electrolytic lesions of the AP located close to the commNTS in
young SHR also impair development of hypertension chroni-
cally by mechanisms not yet completely understood (25).
In the forebrain, one area strongly involved in development
and maintenance of different models of experimental hyper-
tension is the tissue surrounding the anteroventral third ventri-
cle (AV3V region) (7, 8, 9, 22, 23, 26). The AV3V region
includes periventricular preoptic nuclei surrounding the antero-
ventral part of the third ventricle and the organum vasculosum
of the lamina terminalis, an area lacking blood-brain barrier
and rich in ANG II receptors (9, 10, 11, 22). In rats, electrolytic
lesions of the AV3V region abolish or reduce pressor responses
dependent on sympathetic activation and/or vasopressin secre-
tion like pressor responses to central ANG II or cholinergic
activation, without changing baroreflex and peripheral che-
moreflex (7, 8, 26, 27, 43, 44). AV3V lesions impair the
development of neurogenic hypertension produced by sinoaor-
tic denervation or by ablation of the medial NTS and the
development of renal ANG II-dependent hypertension (7, 9,
22, 23). However, AV3V lesions produce no effect on hyper-
tension in SHR (9, 17).
Based on previous studies, it seems that the main mecha-
nisms involved in the development and maintenance of hyper-
tension in SHR are located in the brain stem, while other
models of hypertension are more dependent on forebrain mech-
anisms (7, 8, 9, 22, 23, 26, 36–38). However, recent studies
showed that AV3V lesions or blockade of cholinergic or
angiotensinergic mechanisms in the forebrain strongly reduces
pressor responses produced by the activation of the NTS and
the rostroventrolateral medulla (RVLM), which suggests that
the activation of brain stem hypertensive mechanisms are
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strongly dependent on forebrain cholinergic and angiotensin-
ergic mechanisms (43, 44, 45).
Important pressor mechanisms are present in different fore-
brain areas, like septal area, subfornical organ (SFO), preoptic
area, medial hypothalamus, and paraventricular nucleus of
hypothalamus (PVN) that are connected with brain stem areas
related to cardiovascular regulation directly or through con-
nections with the AV3V region (9, 12, 22, 23, 42). Studies
have also shown specific neural connections between the
AV3V region and the NTS (34, 35). Therefore, considering
that: 1) previous studies showed that commNTS and AV3V
region are strongly involved in the development and/or main-
tenance of one or more models of hypertension, 2) the exis-
tence of anatomical connections between the two structures,
and 3) the importance of forebrain mechanisms for pressor
responses that arise with the activation of brain stem pressor
mechanisms, in the present study we investigated the effects of
AV3V and commNTS lesions alone or combined on MAP,
HR, and cardiovascular reflexes in SHR. Because the AV3V
region is also strongly involved in the control of fluid-
electrolyte balance (9, 27), we also evaluated the possible
influence of changes in water intake and renal excretion for the
effects of AV3V associated with commNTS lesions on MAP in
SHR. In addition, we also tested whether AV3V and com-
mNTS lesions might affect the activation of sympathetic and
angiotensinergic mechanisms involved in the maintenance of
hypertension in SHR. The results show that AV3V and com-
mNTS lesions combined in the same animal chronically reduce
hypertension in SHR by impairing activation of angiotensin-
ergic and sympathetic mechanisms, while changes in fluid-
electrolyte balance seem to have no role for the antihyperten-
sive effects of these lesions.
MATERIALS AND METHODS
Animals
Experiments were performed in 80 adult male SHR and in 12
control normotensive male Holtzman rats weighing 320–350 g (14 to
17 wk old). The animals were housed individually in stainless steel
cages in a room with controlled temperature (23 2°C) and humidity
(55  10%). Lights were on from 7:00 AM to 7:00 PM. Standard
Guabi chow (Paulinia, SP, Brazil) and tap water were available ad
libitum. All the experiments were performed in conscious, freely
moving rats. The experimental protocols were approved by the Ani-
mal Experimentation Ethics Committee of the School of Dentistry,
Sa˜o Paulo State University (UNESP).
Electrolytic Lesions
Commissural NTS lesions. Rats were anesthetized with intraperi-
toneal injection of ketamine (80 mg/kg of body wt) combined with
xylazine (7 mg/kg of body wt) and placed in a stereotaxic frame
(model 900; David Kopf Instruments). A partial craniotomy of the
occipital bone was performed, and the dorsal surface of the brain stem
was exposed. A tungsten electrode (0.1 mm in diameter) bared at the
tip (0.5 mm) was inserted into the brain 0.1 and 0.5 mm caudal to the
calamus scriptorius, in the midline, and 0.4 mm below the dorsal
surface of the brain stem. Electrolytic lesions were performed using a
cathodal current of 1 mA during 10 s in each one of the two
stereotaxic coordinates cited above as previously described (13, 36,
38). A clip attached to the tail was used as the indifferent electrode.
Sham-lesioned rats were submitted to the same surgical procedures
and had the electrode placed along the same coordinates, except that
no current was passed.
AV3V lesions. The AV3V lesions were also performed in rats
anesthetized with intraperitoneal injection of ketamine (80 mg/kg of
body wt) combined with xylazine (7 mg/kg of body wt) using a
tungsten wire electrode (0.4 mm in diameter) bared at the tip (0.5 mm)
that was inserted into the brain using the following coordinates: 0.0
mm from bregma, in the midline, and 7.0 mm below the dura mater.
Electrolytic lesions were performed using a cathodal current (2 mA
during 10 s) as previously described (12, 27, 41–44). A clip attached
to the tail was used as the indifferent electrode. Sham-lesioned rats
had the electrode placed along the same coordinates, except that no
current was passed. For combined lesions, rats had lesions in the
commNTS followed immediately by AV3V lesions. Rats received a
prophylactic dose of penicillin (30,000 IU) given intramuscularly and
a subcutaneous injection of the analgesic Ketoflex (ketoprofen 1%,
0.03 ml/rat) postsurgically.
Arterial Pressure and HR Recordings
Pulsatile arterial pressure (PAP), MAP, and HR were recorded in
unanesthetized freely moving rats. Under intraperitoneal injection of
ketamine (80 mg/kg of body wt) combined with xylazine (7 mg/kg of
body wt) anesthesia, a polyethylene tubing (PE-10 connected to a
PE-50) was inserted into the abdominal aorta through the femoral
artery. Next, a second polyethylene tubing was inserted into the
femoral vein for drug administration. Both cannulas were tunneled
subcutaneously to the back of the rats and connected to stainless steel
“elbows” made of 23-gauge hypodermic tubing. One end of this
elbow was kept under the skin, and the other end was exteriorized
through the skin. The cannulas were filled with sterile saline contain-
ing heparin (50 U/ml) and penicillin G (1.3 mg/ml, the equivalent to
2,000 U/ml). The external end of the elbow was closed with a plastic
cap, as previously described (39). This method of arterial cannulation
allows daily arterial pressure recordings chronically (for more than a
month) (39). To record PAP, MAP, and HR, a polyethylene tubing
filled with sterile saline connected the arterial line of the external end
of the elbow to a strain gauge transducer (Statham P23Db) coupled to
a preamplifier (model ETH-200; Bridge Bio Amplifier) that was
connected to a Powerlab computer data acquisition system (model
Powerlab 16SP; ADInstruments). Arterial pressure and HR were
recorded from 2 days before until 40 days after brain surgery.
On 1, 2, 3, 5, 10, 15, 20, 30, and 40 days after brain surgery, MAP
and HR were recorded once a day from 8:00 AM to 12:00 AM. In
each rat, the recording period took 1 h. Rats had the arterial line
connected with the transducer, and after 15 min, the recording of
MAP and HR started. MAP and HR were recorded for the next 30–40
min, and the mean of the values of arterial pressure and HR recorded
before starting the intravenous injections were used as the result. One
day before and 1, 5, 10, 20, 30, and 40 days after cerebral lesions,
baro- and chemoreflex were tested with intravenous injections of
phenylephrine (PHE), sodium nitroprusside (SNP), and potassium
cyanide (KCN) at the end of the recording sessions. The interval
between intravenous injections was 5 min.
Daily Food and Water Intake, Body Weight, Urinary Volume,
and Na and K Excretion
To test whether changes on MAP were a consequence of changes
in fluid-electrolyte balance or food intake, the effects of AV3V and
commNTS lesions alone or combined on daily water and food intake,
body weight, urinary volume, and Na and K excretion, in SHR
were investigated. Rats were housed in metabolic cages, and daily
recordings were started 2 days before surgery (control) and continued
until 40 days after lesions. Four groups of SHR (sham, AV3V lesion,
commNTS lesion, and combined lesions) not implanted with arterial
or venous catheters were tested. Plasma osmolality, protein, Na, K,
and hematocrit were also analyzed at the end of 40 days.
For the same purpose, MAP and HR were also recorded for 12 days
in a control group of intact SHR and in a group of intact SHR that had
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available the same amount of water and food that AV3VcommNTS-
lesioned SHR ingested. MAP and HR were recorded for 2 days in
control conditions before starting the reduction in water and food
intake and continued until the 10th day of restriction.
Histology
At the end of the experiments, rats were deeply anesthetized with
sodium thiopental (70 mg/kg of body wt ip). Saline followed by 10%
buffered formalin was perfused through the heart. The brains were
frozen, cut coronally into 50-m sections, stained with Giemsa stain,
and analyzed by light microscopy to confirm the AV3V and com-
mNTS lesions.
Statistical Analysis
Statistical analysis was done with Sigma Stat version 3.0 (Jandel,
Point Richmond, CA). All data are reported as means  SE. One- or
two-way parametric ANOVA followed by the Newman-Keuls multi-
ple comparisons test were used, as appropriate. Significance was set at
P  0.05.
Experimental protocols
Effects of AV3V and commNTS lesions alone or combined on
baseline MAP and HR in SHR. To evaluate the effect of specific brain
lesions on baseline MAP and HR in conscious SHR, resting PAP,
MAP, and HR were recorded for the next 3 days after cannulation of
the femoral artery and vein. At the end of the third recording period,
animals were submitted to sham or commNTS lesions combined with
sham or AV3V lesions. On 1, 2, 3, 5, 10, 15, 20, 30, and 40 days after
central lesions, resting MAP and HR were recorded. Four groups of
SHR were tested: sham AV3V lesionsham commNTS lesion, sham
AV3V lesioncommNTS lesion, AV3V lesionsham commNTS
lesion, and AV3V lesioncommNTS lesion.
Effects of AV3V and commNTS lesions on chemoreflexes and
baroreflexes in SHR. One day before and 1, 5, 10, 20, 30 and 40 days
after cerebral lesions, at the end of the session of MAP and HR
recording, rats had baroreflexes and chemoreflexes tested to investi-
gate whether the reflexes were influenced by brain lesions. Chemore-
flex was tested with an intravenous bolus injection of KCN (40 g 0.1
ml1  rat1). Baroreflex was tested injecting intravenously a pressor
dose of phenylephrine (PHE; 5 g/kg of body wt) and a depressor
dose of SNP (30 g/kg of body wt).
Daily water and food intake, renal excretion, and body weight in
AV3V- and commNTS-lesioned SHR. Four groups of SHR (sham,
AV3V lesion, commNTS lesion, and combined lesions) different from
those used to record MAP and HR, were used to test specifically daily
water and food intake, renal Na, K, and volume excretion, and
body weight. Daily recordings started 2 days before surgery (control)
and continued until 40 days after lesions.
Arterial pressure and HR in intact SHR with reduced amount of
food and water available. To show that the reduction in baseline MAP
after combined AV3VcommNTS lesions is not related to the reduc-
tion in water and/or food ingestion produced by these lesions, MAP
and HR were recorded for 13 days in a control group of intact SHR
and in a group of intact SHR that had available the same amount of
water and food that AV3VcommNTS-lesioned SHR ingested. MAP
and HR were recorded for 3 days in control conditions before starting
the reduction in water and food intake and continued until the 10th
day of restriction.
Sympathetic and angiotensinergic activities in AV3V- and
commNTS-lesioned SHR. Previous studies have shown that sympa-
thetic activity and ANG II are increased in SHR (7, 15, 24, 30). To test
whether the reduction in MAP produced by AV3VcommNTS le-
sions would be dependent on changes in sympathetic activity and/or
ANG II mechanisms, at the 40th day after lesions, unanesthetized
freely moving SHR received intravenous injections of losartan (ANG
II AT1 receptor antagonist, 10 mg/kg of body wt). On the next day, in
the same groups of rats, autonomic blockade was performed with
intravenous injections of hexamethonium (10 mg/kg of body wt).
Doses of losartan and hexamethonium were based on previous studies
that showed the efficacy of these doses for blocking AT1 receptors and
sympathetic activity (2, 6, 14, 18, 28, 32, 46, 47).
Effects of combined AV3V and commNTS lesions on baseline MAP,
HR, and cardiovascular reflexes in normotensive rats. To confirm
results from previous studies (36–38) showing that commNTS lesions
do not affect MAP in normotensive rats and to demonstrate that
combined AV3VcommNTS lesions specifically reduce MAP in
SHR and not in normotensive rats, the effects of these lesions on MAP
and HR were tested also in normotensive rats.
In normotensive rats, recording of resting MAP and HR started 2
days after cannulation of femoral artery and vein. On the third day
after starting recordings, rats were submitted to sham or combined
commNTS and AV3V lesions, and the recordings were continued for
the next 5 days. One day before and 1, 2, 3, 4, and 5 days after cerebral
lesions, at the end of the session of MAP and HR recording, the rats
had baroreflexes tested with intravenous injections of PHE and SNP
and chemoreflexes tested with intravenous injection of KCN.
RESULTS
Histological Analysis
Lesions of the commNTS were located in the midline above
the central canal and extended from the level of the obex to1
mm caudal to the obex (Fig. 1A). Lesions completely destroyed
the commNTS but did not destroy the area postrema or lateral
regions of the NTS. The extension of the lesions was similar to
that performed in previous studies (13, 36, 38). The AV3V
lesions (Fig. 1B) were located between the anterior commis-
Fig. 1. Location of commissural nucleus of
the solitary tract (commNTS) and anteroven-
tral third ventricle (AV3V) lesions. Photomi-
crographs showing the typical lesions (arrow-
heads) of commNTS (A) and AV3V region
(B). The commNTS lesions extended for
800 m rostrocaudally. According the atlas
of Paxinos and Watson (31), the sections ex-
tend from bregma 13.8 to bregma 14.6
mm. The AV3V lesions extended for 540
m rostrocaudally. According the atlas of
Paxinos and Watson (31), the sections extend
from bregma0.26 to bregma0.8 mm. AP,
area postrema; cc, central canal; XII, hypo-
glossal nucleus; AC, anterior commissure; oc,
optic chiasm. Scale bar  0.5 mm.
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sure and the floor of the third ventricle with bilateral damage of
the periventricular tissues from the lamina terminalis through
the preoptic and anterior hypothalamus, never extending cau-
dally to the arcuate nucleus or medial hypothalamus (8, 10, 12,
26, 27, 41, 43, 44). The brain structures that were consistently
destroyed by AV3V lesions were the preoptic periventricular
nuclei, the ventral part of median preoptic nucleus, and the
anterior wall of the third ventricle with the associated organum
vasculosum of the lamina terminalis. Partial destruction of the
medial preoptic nuclei and the medial region of the anterior
hypothalamic nuclei were also observed in some animals.
From a total of 61 rats submitted to commNTS and/or AV3V
lesions, 19 had complete lesions in the commNTS, 20 had
complete lesions of the AV3V region, and 22 had complete
lesions in both structures. The criteria for exclusion of animals
was based upon histological analysis. Only data from rats with
complete lesions of the AV3V region and/or commNTS con-
firmed by histological analysis were included in the results.
Effects of AV3V and commNTS Lesions Alone or Combined
on Baseline MAP and HR in SHR
From a prelesion level of 192  4 mmHg, MAP was
reduced to a level between 121  2 and 127  3 mmHg from
1 to 5 days after commNTS lesions alone in SHR. After 5 days
of lesion, MAP started increasing and returned to prelesion
levels 15 days after commNTS lesions (Fig. 2A). CommNTS
lesion alone did not affect HR (Fig. 2B).
Lesions of the AV3V region alone did not affect baseline
MAP in SHR (Fig. 2A). However, by the combining of
AV3VcommNTS lesions in SHR, MAP was reduced during
the whole period of recording (40 days) (Fig. 2, A and C). From
a prelesion level of 186  4 mmHg, MAP was reduced to a
level between 119  2 and 150  4 mmHg in the first 10 days
after combining AV3VcommNTS lesions and reached 161
4 mmHg 40 days after lesions [F (3, 29)  128.12, P  0.01]
(Fig. 2, A and C). AV3V lesions alone or combined with
commNTS lesions increased HR [F (3, 29)  378.31, P 
0.01] (Fig. 2, B and C).
Effects of AV3V and commNTS Lesions on Chemoreflexes
and Baroreflexes in SHR
AV3V lesions alone did not affect the pressor and brady-
cardic responses produced by peripheral chemoreceptor acti-
vation with intravenous injection of KCN in SHR (Fig. 3A).
However, commNTS lesions alone or combined with AV3V
lesions almost abolished the pressor responses to intravenous
KCN for the whole period of study [F(3, 29) 63.4, P 0.01]
(Fig. 3A). The bradycardia induced by intravenous KCN in
SHR was attenuated from 1 to 10 days after commNTS lesions
alone or combined with AV3V lesions [F(3, 29)  102.6, P 
0.01] (Fig. 3A).
AV3V and commNTS lesions (alone or combined) did not
modify the pressor and bradycardic responses to intravenous PHE
in SHR (Fig. 3B). However, commNTS lesions (1 to 10 days),
Fig. 2. Baseline mean arterial pressure (MAP)
and heart rate (HR) in AV3V- and/or com-
mNTS-lesioned spontaneously hypertensive
rats (SHR). A: baseline MAP and B: baseline
HR on control days (prelesion) and 1, 2, 3, 5,
10, 15, 20, 30, and 40 days after sham, AV3V,
commNTS, or AV3VcommNTS lesions in
SHR. C: representative recordings showing
changes in pulsatile arterial pressure (PAP),
MAP, and HR in 1 SHR submitted to sham
lesions (C1) and 1 SHR submitted to com-
bined AV3VcommNTS lesions on the con-
trol day (prelesion) and 1, 5, 10, 20, 30, and 40
days after lesions (C2). Results in A and B are
represented as means  SE. *P  0.01 com-
pared with sham-lesioned group by 2-way re-
peated-measures ANOVA followed by New-
man-Keuls multiple comparison test. Dashed
line shows prelesion levels of MAP and HR.
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alone or combined with AV3V lesions, attenuated the reflex
tachycardia to intravenous injection of SNP [F(3, 29)  111.23;
P  0.05] without changing the hypotension in SHR (Fig. 3C).
Fluid-Electrolyte Balance and Body Weight in
AV3V- and commNTS-Lesioned SHR
All four groups of rats reduced water and food intake in the
next 2 days after brain surgery (Fig. 4, A and B). In the first 10
days after AV3V lesion alone or combined with commNTS
lesion, daily water intake was reduced [F(3, 29) 322.74; P
0.05] (Fig. 4A). Strong reduction of water intake (80%) oc-
curred in the first 4 days after lesions. No significant difference
in daily water intake was observed between sham- and com-
mNTS-lesioned rats (Fig. 4A).
In sham- or AV3V-lesioned rats, food intake and body
weight were reduced only in the first 2 days after lesions (Fig.
4, B and C). However, food intake was reduced in the first 10
days and body weight in the first 15 days after commNTS
lesion alone or combined with AV3V lesion (Fig. 4, B and C).
Strong reduction of food intake (80%) occurred in the first 4
days after commNTS lesion alone or combined with AV3V
lesion. The maximum reduction of body weight occurred
between 5 and 10 days after commNTS lesion alone or com-
bined with AV3V lesion. After 10 days of lesion, rats started to
gain weight, and their body weight paralleled with sham- or
AV3V-lesioned rats after 15 days of lesion (Fig. 4, B and C).
The changes in water intake and food intake in rats with AV3V
and commNTS lesions seem not to be due to impairment of
motor activity. Although motor activity was not quantified,
visual observation in their home cages and during handling
revealed no apparent differences in reactivity or locomotion
between sham and lesioned SHR.
Sodium excretion was reduced in the first 7 days in all
groups of SHR, probably as a result of the reduction in water
and/or food intake (Fig. 4E). After 7 days, Na excretion
returned to normal level for all groups and was maintained
in this level until the 40th day. There were no significant
changes in K excretion and urinary volume in all group of
SHR over the 40 days after AV3V and commNTS lesion
(Fig. 4, D and F).
Considering only daily water intake and urinary volume, daily
water balance was reduced in the first 3 days after lesions in all
groups tested. In the first 5 days after lesions, reduction of water
balance was more intense in AV3V- or AV3VcommNTS-
lesioned SHR (11 to 7 ml/day) than in sham- or commNTS-
lesioned SHR (4 to 29 ml/day) [F(3, 29)  153.34; P  0.05].
There were also no significant differences in plasma osmolality,
protein, Na and K, and hematocrit between sham- and
AV3VcommNTS-lesioned SHR at the end of 40 days (Table 1).
Arterial Pressure and HR in Intact SHR with Reduced
Amount of Food and Water Available
As described above, water and food intake were significantly
reduced after AV3V and commNTS lesions during 10 days.
Daily water intake in AV3VcommNTS-lesioned rats ranged
from 8  4 ml in the first day after lesions to 12  5 ml in the
10th day, and food intake ranged between 3  5 and 5  6 g
in the same period, while controls ingested an average of
32  5 ml of water and 23  4 g of food daily along the
same period.
Before food and water restriction were started, MAP values
were 183  4 and 185  3 mmHg, respectively, in the control
group and in the group to be submitted to food and water
restriction. Food and water restriction did not change MAP,
Fig. 3. Chemoreflex and baroreflex in AV3V- and/or commNTS-lesioned SHR. Changes in MAP (	 MAP) and HR (	 HR) produced by potassium cyanide
(KCN; 40 g/rat iv) (A); phenylephrine (PHE; 5 g/kg of body wt iv) (B), and sodium nitroprusside (SNP; 30 g/kg of body wt) (C) on the control day (prelesion)
and 1, 5, 10, 20, 30, and 40 days after sham, AV3V, commNTS, or AV3VcommNTS lesions in SHR. Results are represented as means  SE. *P  0.01
compared with sham-lesioned group by 2-way repeated-measures ANOVA followed by Newman-Keuls multiple comparison test.
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and values ranged between 185  2 and 188  4 mmHg from
the first to the 10th day after the reduction of water and food
intake [F (1, 21)  1.12, P 
 0.05] (Fig. 5A). Food and water
restriction also did not affect baseline HR in SHR [F (1, 21) 
1.35, P 
 0.5] (Fig. 5B).
Sympathetic and Angiotensinergic Activities
in AV3V- and commNTS-Lesioned SHR
Compared with sham-lesioned SHR, intravenous losartan
produced a smaller reduction of MAP in AV3V-lesioned rats
and in AV3VcommNTS-lesioned SHR (Fig. 6). Ganglionic
blockade with hexamethonium produced a smaller reduction in
MAP only in AV3VcommNTS-lesioned SHR (Fig. 6). Com-
pared with sham-lesioned SHR, losartan and hexamethonium
did not produce significant changes in HR in all groups of SHR
(data not showed). The efficacy of the blockade of AT1
receptors by losartan was also confirmed with intravenous
injection of ANG II (50 ng/kg) (4  3 mmHg vs. ANG II:
29  6 mmHg, P  0.05).
Effects of Combined AV3V and commNTS Lesions
on Baseline MAP, HR, and Cardiovascular Reflexes
in Normotensive Rats
Combined AV3VcommNTS lesions in normotensive rats
abolished the pressor responses and reduced the bradycardia
produced by intravenous injection of KCN (40 g 0.1
ml1  rat1), during the whole period of study (5 days) [F(1,
44)  103.18; P  0.05], without changing the pressor and
bradycardic responses to intravenous PHE (5 g/kg of body
wt) (See Suppl. Fig. 1 in online version of this article).
However, similar to SHR, combined AV3VcommNTS le-
sions in normotensive rats attenuated the reflex tachycardia to
intravenous injection of SNP (30 g/kg of body wt) [F(1,
44)  78.64; P  0.05], without changing hypotension (see
Suppl. Fig. 2, online).
Fig. 4. Daily water intake, food intake, body weight, urinary volume, Na and K excretion in AV3V- and/or commNTS-lesioned SHR. Daily water intake
(A), food intake (B), body weight (C), urinary volume (D), Na excretion (E), and K excretion (F) on control days (prelesion) and 1, 2, 3, 5, 10, 15, 20, 30,
and 40 days after sham, AV3V, commNTS, or AV3VcommNTS lesions in SHR. Results are represented as means  SE. *P  0.05 compared with
sham-lesioned group by 2-way repeated-measures ANOVA followed by Newman-Keuls multiple comparison test.
Table 1. Plasma Na, K, protein, hematocrit,
and osmolality in sham- or 40-day AV3V 
commNTS-lesioned SHR
Groups Na, meq/l K, meq/l Protein, g/dl Hematocrit, %
Osmolality,
mOsm
Sham 1410.7 5.60.1 6.20.04 420.6 158638
Lesion 1420.4 5.70.4 6.10.14 390.2 164830
Results are means  SE, n  6–7 rat. AV3V, anteroventral third ventricle;
commNTS, commissural nucleus of the solitary tract; SHR, spontaneously
hypertensive rats.
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DISCUSSION
Present results provide the first direct evidence that
AV3VcommNTS electrolytic lesions produce a long-lasting
reduction in arterial pressure (for at least 40 days) in adult
SHR, which suggests that forebrain and brain stem mecha-
nisms, particularly those related to AV3V region and com-
mNTS, act to maintain hypertension in SHR. The reduction in
MAP produced by AT1 receptor or ganglionic blockade in
AV3VcommNTS-lesioned SHR was smaller than the changes
in MAP produced by the same treatments in sham-lesioned
SHR, which suggests that the antihypertensive effects of these
lesions are probably related to reduction in ANG II and
sympathetic-mediated pressor mechanisms. In normotensive
rats, combined commNTSAV3V lesions produced only a
small and transitory reduction of MAP (20 mmHg only in the
first day after lesions), which is evidence that these lesions
affect only mechanisms activated to produce hypertension, not
those that maintain normotensive levels of arterial pressure.
Caution must be exercised when interpreting the effects of
electrolytic lesions, because these lesions also destroy fibers of
passage in addition to cell bodies. In spite of this, electrolytic
lesions have been used as a first approach to investigate the
importance of central areas in different physiological or phar-
macological responses (12, 13, 36–38, 41, 43, 44). Specifi-
cally, considering the present results, it is important to remem-
ber that similar to electrolytic lesions of the commNTS, the
blockade of neuron activity with muscimol injected into the
commNTS also reduces MAP (37). Analysis of the effects of
AV3V lesions is a little more complex because this lesion,
besides fibers of passage, also encompasses more than one
nucleus (9, 10, 23), and only specific lesions in each one of
these structures included in the AV3V region can show which
one plays a role in the maintenance of hypertension in SHR.
However, if the effects of AV3V and commNTS lesions were
due to destruction of cell bodies or fibers of passage, the
interesting point is that hypertension in SHR is maintained by
activation of forebrain and brain stem pressor mechanisms that
deserve more detailed investigation in future studies.
AV3V lesions alone or combined with commNTS lesions
reduced water intake, renal excretion, and water balance, while
commNTS lesions alone or combined with AV3V lesions
reduced food intake. However, the antihypertensive effects of
AV3VcommNTS lesions in SHR cannot be attributed to
changes in fluid-electrolyte balance or food intake because:
1) the changes in fluid-electrolyte balance produced by com-
bined AV3VcommNTS lesions were similar to the changes
produced by AV3V lesions alone that have no effect on MAP
in SHR and 2) MAP did not change in intact SHR that had
restriction of food and water to the same level ingested by
AV3VcommNTS-lesioned SHR. In addition, the antihyper-
tensive effects of commNTS lesions alone or combined with
AV3V lesions cannot be attributed to changes in baroreflexes,
because reflex responses to intravenous PHE or SNP were not
significantly modified by these lesions in normotensive rats or
SHR (13, 36, 38, 43, 44, and present results).
The AV3V region is rich in ANG II receptors and is
reciprocally connected with different central areas, including
those that are part of the medullary circuitry related to cardio-
vascular regulation (7, 8, 22, 23, 34, 35). The AV3V region
receives important direct descending afferent connections from
the SFO, another circumventricular organ in the forebrain
lacking blood-brain barrier and rich in ANG II receptors, and
also direct ascending afferent projections from the parabrachial
Fig. 6. Changes in MAP produced by losartan or hexamethonium intravenous
in AV3V- and/or commNTS-lesioned SHR. Changes in MAP produced by
losartan (10 mg/kg of body wt iv) or hexamethonium (10 mg/kg of body wt iv)
in sham- and 40-day AV3V-, commNTS-, and AV3VcommNTS-lesioned
SHR. Results are represented as means  SE. *P  0.05 compared with
sham-lesioned group by 1-way ANOVA followed by Newman-Keuls multiple
comparison test.
Fig. 5. Baseline MAP and HR in SHR submitted to water and food restriction.
Baseline MAP (A) and baseline HR (B) in control SHR that had ad libitum
access to water and food and in SHR that had restriction of water and food.
Results are represented as means  SE.
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nucleus and from different medullary regions containing cathe-
colamine cell bodies. It was also described direct efferent
projections from the AV3V region to the SFO, PVN, supraop-
tic nucleus, ventral tegmental area, parabrachial nucleus, and
mesencephalic central gray matter (8, 9, 23, 35). Therefore,
AV3V lesions may affect the activity of areas like supraoptic
nucleus and PVN involved in vasopressin secretion. The PVN
is also an important area involved in the control of sympathetic
activity through direct connections with the intermediolateral
cell column, or RVLM, and AV3V lesions may also impair this
function. The NTS that receives important cardiovascular af-
ferent signals sends projections to hindbrain areas like caudal
ventrolateral medulla (CVLM), RVLM, parabrachial nucleus,
and medullary regions containing cathecolamine cell bodies
and to forebrain areas like specific hypothalamic nuclei (34,
35). Therefore, the commNTS lesion may impair important
signals that control the activity of CVLM and RVLM, two
main areas of the medullary circuitry involved in cardiovascu-
lar regulation and, in addition, also signals that might reach
directly or indirectly the AV3V region. Besides the inhibitory
signals that reach the RVLM through CVLM, the NTS and
PVN are also important sources of excitatory inputs to RVLM
and the sympathetic system. Lesion of the commNTS disrupts
mainly excitatory inputs from the NTS to RVLM without
changing the inhibitory inputs, and AV3V lesion may impair
excitatory inputs from the PVN. According to the present
results, it seems that the blockade of both mechanisms is
necessary to reduce MAP in SHR.
The fall in MAP produced by the blockade of ANG II
receptors with intravenous losartan was reduced by 60 to 70%
in AV3V, or commNTSAV3V-lesioned SHR, while com-
mNTS lesions did not affect the responses to intravenous
losartan, which suggests that angiotensinergic pressor mecha-
nisms are impaired in rats with AV3V lesions. The fall in MAP
produced by intravenous hexamethonium was reduced by 50%
only in SHR with combined AV3VcommNTS lesions, not in
SHR with lesions in only one structure, which suggests that
sympathetic activity is reduced in SHR with combined lesions.
Therefore, reduction in sympathetic and angiotensinergic ac-
tivities in SHR with AV3VcommNTS lesions seems to be
the cause of the antihypertensive effects of these combined
lesions. The AV3V lesions impair the pressor responses to
central angiotensinergic and cholinergic activation, to gluta-
mate injected into the NTS and RVLM, to the pressor response
to carotid occlusion, and prevent the development of neuro-
genic hypertension produced by sinoaortic denervation or by
ablation of the medial NTS and the development of many other
models of experimental hypertension, including renal ANG
II-dependent hypertension, without changing baroreflex and
peripheral chemoreflex in normotensive rats (7, 8, 9, 12, 42, 43,
44). All of these effects suggest that AV3V lesions reduce
sympathetic- and angiotensinergic-mediated pressor responses
in normotensive rats. However, as shown by the present re-
sults, the fall in MAP produced by intravenous hexamethonium
was not modified by AV3V lesions, suggesting that AV3V
lesions alone do not affect the high sympathetic activity in
SHR. Considering that AV3V lesions strongly reduce the
action of angiotensinergic pressor mechanisms, the mainte-
nance of hypertension in AV3V-lesioned SHR seems to de-
pend mainly on the high sympathetic activity not affected by
AV3V lesions. Chronic commNTS lesions do not affect the fall
in MAP produced by intravenous losartan or hexamethonium,
which suggests that angiotensinergic and sympathetic pressor
mechanisms are acting normally in chronic commNTS-le-
sioned SHR. However, reduced MAP and sympathetic activity
occur in commNTSAV3V-lesioned SHR, which in addition
also have reduced angiotensinergic activity. Therefore, the
maintenance of high sympathetic activity is an important
mechanisms for hypertension in SHR and only the combined
lesions that reduce sympathetic and angiotensinergic activities
also reduce resting MAP chronically in SHR. Probably when
one area is destroyed the other replace the function, i.e., in the
absence of AV3V region, commNTS maintains the high sym-
pathetic activity and hypertension and vice versa. Reduction in
the action of angiotensinergic mechanisms may also contribute
for the antihypertensive effects of AV3VcommNTS lesions
in SHR; however, as evidenced in AV3V-lesioned rats, only
the reduction of angiotensinergic mechanisms is not enough to
reduce MAP chronically in SHR. In spite of the reduction in
baseline MAP by AV3VcommNTS lesions in SHR, it is
important to note that MAP was still a little above normoten-
sive level, which suggests that other mechanisms, not depen-
dent on these two areas, are also involved in the maintenance
of hypertension in SHR.
It has been suggested that sympathetic activity consists of
rhythmic discharges produced by supraspinal structures, par-
ticularly multiple oscillatory networks in the brain stem (3–5).
Acute inhibition of commNTS neurons similar to PVN inhibi-
tion decreases sympathetic activity in SHR but not in normo-
tensive control Wistar-Kyoto rats (1, 37). These results are
usually interpreted as evidence that RVLM neurons are more
active in SHR, either because they receive more excitatory
inputs or less GABAergic inhibition (21). There is a suggestion
that under resting conditions, arterial chemoreceptors have a
high activity in SHR, which causes sympathetic hyperactivity
and high arterial pressure in this strain (16, 19, 33, 40). Acute
or chronic lesions of the commNTS abolish the pressor re-
sponses to peripheral chemoreflex activation (13, 28), which
might be a mechanism to reduce sympathetic activation and
arterial pressure in SHR (36, 37, 38). However, in commNTS-
lesioned SHR, MAP recovers prelesion hypertensive levels chron-
ically, in spite of the chronic impairment of chemoreflex re-
sponses, which suggests that other mechanisms are activated to
recover high arterial pressure in chronic commNTS-lesioned
SHR. An impairment of respiration increasing blood PCO2 and/or
reducing PO2 in commNTS-lesioned SHR might also increase
arterial pressure, allowing the recovery of precommNTS lesion
hypertensive levels. In this case, the blockade of the pressor
responses to changes in blood gases might be the effect of
AV3V lesions. However, unpublished results from our labora-
tory have shown that electrolytic lesions or muscimol injec-
tions into the commNTS did not affect baseline respiration,
although they reduced the increase in breathing produced by
peripheral chemoreceptor activation in normotensive rats.
Therefore, probably an AV3V-dependent mechanism, not re-
lated to respiratory changes, recovers sympathetic activity
chronically after commNTS lesions.
Electrolytic lesions of the area postrema also impair the
development of hypertension in SHR (25). However, as com-
mented by the authors, lesions of the area postrema may also
partially affect NTS, particularly commNTS. Indeed, the
present and previous studies have suggested that commNTS
R1804 ANTIHYPERTENSIVE EFFECTS OF BRAIN LESIONS IN SHR
AJP-Regul Integr Comp Physiol • VOL 296 • JUNE 2009 • www.ajpregu.org
lesions, which do not affect the integrity of the area postrema,
reduce hypertension (36, 38). Therefore, it is still not clear
whether the reduction of arterial pressure in SHR by lesions of
the area postrema is due to impairment of the area postrema
alone or commNTS mechanisms. Perhaps commNTS and area
postrema are part of the same mechanism that can be disrupted
by area postrema or commNTS lesions. It is also important to
note that lesions of the area postrema were performed in
4-wk-old SHR or before they became hypertensive, and we
found no study showing effects of lesions of the area postrema
in adult hypertensive SHR.
In summary, the present results suggest that hypertension in
SHR is strongly dependent on central complex mechanisms in-
volving multiple central areas and probably different mechanisms.
One mechanism may compensate for the absence of the other,
which increases the probability of hypertension in these animals.
The antihypertensive effects of commNTSAV3V lesions in
SHR seem to depend on reduction of angiotensinergic and sym-
pathetic pressor mechanism activation. Changes in fluid-electro-
lyte balance or food intake are probably not important.
Perspectives and Significances
Future studies using different approaches are necessary to
confirm the mechanisms dependent on the AV3V region and
commNTS involved in the maintenance of hypertension
in SHR. The existence of more than one mechanism to main-
tain hypertension in SHR is an important point to be considered
in future studies, because the absence of effects blocking one
particular mechanism does not mean that it is not involved in
the development or maintenance of hypertension in SHR.
Studies observing an absence of the effect of altering one brain
region may overlook the importance of that region unless
multiple regions are considered. Clearly the maintenance of
hypertension in SHR involves complex, redundant, central
mechanisms that should be examined simultaneously.
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